[HTML] frontiersin.org

[HTML][HTML] Anlotinib inhibits PFKFB3-driven glycolysis in myofibroblasts to reverse pulmonary fibrosis

W Chen, J Zhang, W Zhong, Y Liu, Y Lu… - Frontiers in …, 2021 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is a fatal disease in which the normal alveolar network is
gradually replaced by fibrotic scars. Current evidence suggests that metabolic alterations …
被引用次数：24 相关文章

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis

W Chen, J Zhang, W Zhong, Y Liu… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a fatal disease in which the normal alveolar network is
gradually replaced by fibrotic scars. Current evidence suggests that metabolic alterations …

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis

W Chen, J Zhang, W Zhong, Y Liu, Y Lu… - Fibrosis in the …, 2022 - books.google.com
MATERIALS AND METHODS Fibrosis can develop in most organs and cause organ failure.
The most common type of lung fibrosis is idiopathic pulmonary fibrosis (IPF), which is highly …
[HTML] nih.gov

[HTML][HTML] Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis

W Chen, J Zhang, W Zhong, Y Liu, Y Lu… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a fatal disease in which the normal alveolar network is
gradually replaced by fibrotic scars. Current evidence suggests that metabolic alterations …

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis.

W Chen, J Zhang, W Zhong, Y Liu, Y Lu… - Frontiers in …, 2021 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a fatal disease in which the normal alveolar network is
gradually replaced by fibrotic scars. Current evidence suggests that metabolic alterations …